Insider · CIK 0001221590

BIENAIME JEAN JACQUES

Reports to the SEC for 11 companies · HELLERUP

sec.gov

Transactions

Companies

Filings

CIK

0001221590

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-17	KROSKeros Therapeutics, Inc.P Purchase	Director	PPurchase	+1,000 sh	$10.27	+$10.3K	19,592
2026-08-14	ASNDAscendis Pharma A/SP Purchase	Director	PPurchase	+1,100 sh	$245.85	+$270K	2,000
2026-08-14	ASNDAscendis Pharma A/SP Purchase	Director	PPurchase	+900 sh	$246.91	+$222K	2,900
2026-07-15	KROSKeros Therapeutics, Inc.P Purchase	Director	PPurchase	+1,000 sh	$10.61	+$10.6K	18,592
2026-06-15	KROSKeros Therapeutics, Inc.P Purchase	Director	PPurchase	+1,000 sh	$10.19	+$10.2K	17,592
2026-06-10	IMNMImmunome Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+9,897 sh	—	—	9,897
2026-06-08	INCYINCYTE CORPA Award	Director	AAward	+1,642 sh	—	—	24,424
2026-06-08	INCYINCYTE CORP · Non Qualfied Stock Option (right to buy)A Award	Director	AAward	+6,111 sh	—	—	6,111
2026-06-05	IMNMImmunome Inc.S Sale	Director	SSale	−10K sh	$19.41	−$194K	32,915
2026-06-05	IMNMImmunome Inc.P Purchase	Director	PPurchase	+6,000 sh	$19.48	+$117K	38,915
2026-06-05	IMNMImmunome Inc.P Purchase	Director	PPurchase	+1,000 sh	$19.27	+$19.3K	43,415
2026-06-05	IMNMImmunome Inc.S Sale	Director	SSale	−500 sh	$19.44	−$9,720	42,915
2026-06-05	IMNMImmunome Inc.P Purchase	Director	PPurchase	+3,500 sh	$19.46	+$68.1K	42,415
2026-06-03	KROSKeros Therapeutics, Inc.A Award	Director	AAward	+7,142 sh	—	—	16,592
2026-06-03	KROSKeros Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,433 sh	—	—	7,433
2026-05-29	ASNDAscendis Pharma A/SP Purchase	Director	PPurchase	+100 sh	$223.50	+$22.4K	900
2026-05-29	ASNDAscendis Pharma A/SP Purchase	Director	PPurchase	+200 sh	$222.30	+$44.5K	800
2026-05-29	ASNDAscendis Pharma A/SP Purchase	Director	PPurchase	+200 sh	$223.76	+$44.8K	600
2026-05-26	INCYINCYTE CORPM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$84.53	+$1.27M	35,841
2026-05-26	INCYINCYTE CORPF Tax Payment	Director	FTax Payment	−13.1K sh	$97.10	−$1.27M	22,782
2026-05-26	ASNDAscendis Pharma A/SP Purchase	Director	PPurchase	+200 sh	$236.24	+$47.2K	200
2026-05-26	INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2026-05-26	ASNDAscendis Pharma A/SP Purchase	Director	PPurchase	+200 sh	$239.37	+$47.9K	400
2026-05-15	IMNMImmunome Inc.P Purchase	Director	PPurchase	+5,000 sh	$20.70	+$104K	43,415
2026-05-15	KROSKeros Therapeutics, Inc.P Purchase	Director	PPurchase	+1,000 sh	$10.58	+$10.6K	9,450
2026-04-15	KROSKeros Therapeutics, Inc.P Purchase	Director	PPurchase	+1,000 sh	$11.70	+$11.7K	8,450
2026-04-14	ASNDAscendis Pharma A/S · WarrantsA Award	Director	AAward	+9,160 sh	—	—	9,160
2026-04-14	ASNDAscendis Pharma A/S · WarrantsD Disposition to Issuer	Director	DDisposition to Issuer	−9,160 sh	—	—	0
2026-03-11	IMNMImmunome Inc.P Purchase	Director	PPurchase	+1,000 sh	$21.55	+$21.6K	38,415
2026-03-10	IMNMImmunome Inc.P Purchase	Director	PPurchase	+1,000 sh	$22.12	+$22.1K	37,415
2026-03-09	KROSKeros Therapeutics, Inc.P Purchase	Director	PPurchase	+2,000 sh	$11.21	+$22.4K	7,450
2025-06-10	IMNMImmunome Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+18.9K sh	—	—	18,864
2025-06-10	INCYINCYTE CORP · Non Qualfied Stock Option (right to buy)A Award	Director	AAward	+9,216 sh	—	—	9,216
2025-06-10	INCYINCYTE CORPA Award	Director	AAward	+2,518 sh	—	—	20,841
2025-06-04	KROSKeros Therapeutics, Inc.A Award	Director	AAward	+5,250 sh	—	—	5,450
2025-06-04	KROSKeros Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10.5K sh	—	—	10,500
2025-06-03	IMNMImmunome Inc.P Purchase	Director	PPurchase	+5,000 sh	$9.38	+$46.9K	36,415
2025-03-25	IMNMImmunome Inc.P Purchase	Director	PPurchase	+7,800 sh	$7.78	+$60.7K	31,415
2025-03-24	IMNMImmunome Inc.P Purchase	Director	PPurchase	+7,000 sh	$8.21	+$57.5K	23,615
2024-08-16	IMNMImmunome Inc.P Purchase	Director	PPurchase	+7,000 sh	$13.94	+$97.6K	16,615
2024-06-13	IMNMImmunome Inc. · Stock option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,333
2024-06-12	INCYINCYTE CORPA Award	Director	AAward	+2,830 sh	—	—	18,323
2024-06-12	INCYINCYTE CORP · Non Qualfied Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,517
2024-06-03	KROSKeros Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.6K sh	—	—	17,600
2024-05-21	IMNMImmunome Inc.P Purchase	Director	PPurchase	+2,000 sh	$13.57	+$27.1K	9,615
2024-05-20	BMRNBIOMARIN PHARMACEUTICAL INCF Tax Payment	Director	FTax Payment	−1,202 sh	$77.05	−$92.6K	473,792
2024-05-10	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Option (Right to Buy Common Stock)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	51,000
2024-05-10	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$63.10	+$1.26M	494,994
2024-05-10	BMRNBIOMARIN PHARMACEUTICAL INCS Sale	Director	SSale	−20K sh	$81.14	−$1.62M	474,994
2024-05-09	BMRNBIOMARIN PHARMACEUTICAL INCM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$63.10	+$1.26M	494,994

Recent filings

Accepted (ET)
Sep 284
BIENAIME JEAN JACQUES0001610717-26-000423
SEC(opens sec.gov)
Aug 194
BIENAIME JEAN JACQUES0001221590-26-000025
SEC(opens sec.gov)
Aug 184
BIENAIME JEAN JACQUES0001610717-26-000360
SEC(opens sec.gov)
Jul 174
BIENAIME JEAN JACQUES0001221590-26-000023
SEC(opens sec.gov)
Jun 174
BIENAIME JEAN JACQUES0001221590-26-000021
SEC(opens sec.gov)
Jun 124
BIENAIME JEAN JACQUES0001221590-26-000018
SEC(opens sec.gov)
Jun 104
BIENAIME JEAN JACQUES0001221590-26-000017
SEC(opens sec.gov)
Jun 94
BIENAIME JEAN JACQUES0001221590-26-000015
SEC(opens sec.gov)
Jun 54
BIENAIME JEAN JACQUES0001221590-26-000013
SEC(opens sec.gov)
Jun 14
BIENAIME JEAN JACQUES0001610717-26-000177
SEC(opens sec.gov)

Companies

Address

C/O ASCENDIS PHARMA A/S TUBORG BOULEVARD 12

HELLERUP, 2900